section name header

Basics

Basics

Definition

Serum potassium concentration higher than the testing laboratory's upper limit of normal, generally >5.7 mEq/L (mmol/L).

Pathophysiology

  • Potassium is primarily intracellular; serum concentrations do not accurately reflect tissue concentrations.
  • Hyperkalemia is often associated with cellular injury (e.g., trauma and ischemia) and other causes of translocation of potassium out of the intracellular space (e.g., acidosis).
  • Potassium is eliminated in the kidneys and elimination is enhanced by aldosterone; conditions that inhibit renal elimination of potassium will cause hyperkalemia.

Systems Affected

  • Cardiovascular-potassium affects cardiac conduction, and changes are reflected on the ECG; as potassium rises, the T waves become tall and spiked with a narrow base, the QRS complexes widen, and the P-R intervals lengthen; the P waves become smaller and wider and, in animals with severe hyperkalemia, disappear (atrial standstill); higher concentrations of potassium cause fusion of the QRS-T, which causes a wide complex idioventricular rhythm followed by ventricular fibrillation or asystole; ECG changes in animals with hyperkalemia vary and are diminished by hypernatremia, hypercalcemia, and alkalosis.
  • Nervous-neuromuscular function affected.

Signalment

  • Dog and cat
  • Pseudohyperkalemia in certain East Asian dog breeds (e.g., Akita, Shiba, Jindo, and Chinese Shar-Pei)

Signs

Historical Findings

  • Weakness
  • Collapse
  • Flaccid paralysis
  • Death

Physical Examination Findings

In addition to historical findings, arrhythmias, especially bradyarrhythmias, in some animals.

Causes

  • Pseudohyperkalemia-some blood cells (i.e., RBCs [reported in East Asian dog breeds including Akita, Shiba, Jindo, and Chinese Shar-Peisdue to the presence of a Na-K pump in the mature RBC membrane in some animals], platelets, WBCs), contain high concentrations of potassium; if the blood sample is not analyzed or separated promptly, this intracellular potassium is released into the serum, causing the potassium concentration to be artificially high (pseudohyperkalemia).
  • Low potassium elimination-anuric or oliguric renal failure; renal hypoperfusion (complete AV block); urinary tract rupture or urethral obstruction; administration of potassium-sparing diuretics, ACE inhibitors, trimethoprim, nonsteroidal anti-inflammatory drugs, or heparin (causing hypoaldosteronism); some gastrointestinal diseases (e.g., salmonellosis, trichuriasis, duodenal perforation).
  • Translocation of potassium-acidosis, reperfusion syndrome, thrombolysis in feline aortic thromboembolism, tumor lysis syndrome, muscle injury (trauma, phosphofructokinase deficiency), severe digitalis overdose, infusion of mannitol, and hyperglycemia causing hyperosmolality.
  • High potassium intake-oral or parenteral potassium supplements. Potassium bromide toxicosis
  • Miscellaneous-pleural effusion and ascites.

Risk Factors

  • Fluid therapy with potassium supplementation.
  • Parenteral nutrition.
  • Administration of potassium-sparing diuretics (e.g., spironolactone) and ACE inhibitors (e.g., enalapril, benazepril), primarily in patients with renal disease.
  • Conditions associated with acidosis.
  • Trauma.
  • Renal disease.
  • Lower urinary tract disease in male cats.
  • Cystic calculi in male dogs.
  • Thrombocytosis and leukemia.
  • Akita, Shiba, Jindo, and Chinese Shar-Pei-pseudohyperkalemia. Not all animals within a breed are at risk for pseudohyperkalemia. Approximately 20% of Akitas have the high potassium phenotype.
  • Phosphofructokinase deficiency.

Diagnosis

Diagnosis

Differential Diagnosis

  • Waxing and waning history of gastrointestinal complaints, weakness, collapse-consider hypoadrenocorticism.
  • Straining to urinate or low urine output-consider urinary obstruction or oliguric/anuric renal failure.

Laboratory Findings

Disorders That May Alter Laboratory Results

Thrombocytosis (>1,000,000 cells/mm3), leukocytosis (>200,000 cells/mm3), and abnormal (leukemic) leukocytes can cause release of large amounts of potassium into the serum if not separated quickly.

CBC/Biochemistry/Urinalysis

  • In patients with Na:K ratio <27, consider hypoadrenocorticism; some patients with diarrhea and metabolic acidosis, ascites, chylothorax, or pregnancy may also have a low Na:K ratio.
  • In patients with azotemia, consider hypoadrenocorticism, anuric or oliguric renal failure, and ruptured or obstructed urinary tract.
  • In patients with high creatine kinase, aspartate aminotransferase, and lactic dehydrogenase, consider muscle injury.
  • In patients with severe thrombocytosis or leukocytosis or if the patient is an East Asian dog breed, consider pseudohyperkalemia.

Other Laboratory Tests

ACTH response test to rule out hypoadrenocorticism.

Imaging

Radiographic contrast studies or ultrasound to rule out urinary tract rupture or obstruction.

Treatment

Treatment

Medications

Medications

Drug(s) Of Choice

  • Can administer sodium bicarbonate to patients with severe hyperkalemia to induce translocation of potassium into cells; if blood pH and base deficit cannot be determined, administer 1–2 mEq/kg slowly IV; to calculate bicarbonate dose more accurately:
    • Dogs, 0.3 × body weight (kg) × (21 – patient's HCO3)
    • Cats, 0.3 × body weight (kg) × (19 – patient's HCO3)
  • Administer half of dose and reevaluate.
  • Can administer dextrose and regular insulin to patients with severe hyperkalemia to induce translocation of potassium into cells (regular insulin, 0.5 U/kg IV with 50% dextrose, 1 g/kg IV); dextrose can also be used without insulin.
  • For patients with life-threatening hyperkalemia, administer calcium gluconate 10% (0.5–1 mL/kg slowly IV over 10 minutes) while monitoring the ECG; calcium antagonizes the effect of potassium on the conduction system without lowering the potassium concentration.

Contraindications

  • Avoid potassium-containing fluids and fluids that cause hyponatremia, acidosis, or hypocalcemia.
  • Avoid drugs that contain potassium or interfere with potassium elimination (e.g., ACE inhibitors, trimethoprim antibiotics, and potassium-sparing diuretics).

Precautions

  • Kayexalate and sodium bicarbonate cause a sodium load that may lead to fluid retention in patients with cardiac or renal failure.
  • Sodium bicarbonate lowers ionized calcium levels. Use cautiously in hypocalcemic patients.

Alternative Drug(s)

Sodium polystyrene sulfonate (Kayexalate) per os or per rectum binds potassium within the intestinal tract, limiting absorption and reabsorption; rarely used in veterinary practice.

Follow-Up

Follow-Up

Patient Monitoring

  • Recheck potassium at frequency dictated by the underlying disease.
  • Check ECG frequently until rhythm disturbances resolve.

Prevention/Avoidance

  • Monitor potassium in patients receiving drugs that alter potassium elimination.
  • Administer IV potassium at a rate less than 0.5 mEq/kg/h.

Possible Complications

Death of animals with severe hyperkalemia

Miscellaneous

Miscellaneous

Pregnancy/Fertility/Breeding

Combined hyperkalemia and hyponatremia reported in several pregnant dogs.

Abbreviations

  • ACE = angiotensin converting enzyme
  • ACTH = adrenocorticotropic hormone
  • ECG = electrocardiogram/electrocardiography
  • RBC = red blood cell.
  • WBC = white blood cell

Author Francis W.K. Smith, Jr.

Consulting Editor Deborah S. Greco

Suggested Reading

DiBartola SP. Fluid, Electrolyte and Acid-base Disorders in Small Animal Practice, 4th ed. St Louis: Elsevier Saunders, 2011.